Healthcare Holding Schweiz Expands Its Portfolio with QUNIQUE Stake Acquisition

On November 4, 2025, Healthcare Holding Schweiz AG announced its strategic acquisition of a stake in QUNIQUE GmbH, a prominent consulting firm located in Wohlen, Switzerland. This acquisition marks a significant expansion of Healthcare Holding’s expertise in regulatory affairs and quality management within the medical technology sector.

QUNIQUE GmbH is well-known in the industry for its ISO 13485 certification and its crucial role in assisting manufacturers, importers, distributors, hospitals, and suppliers in adhering to regulatory and quality standards within both Switzerland and the European Union. By acquiring a stake in such a reputable firm, Healthcare Holding not only bolsters its service offerings but also enhances its capacity to ensure compliance across the entire value chain.

The founding members of QUNIQUE will now have the opportunity to rejoin the group, strengthening collaborative efforts moving forward. As part of this alliance, QUNIQUE maintains its operational independence and continues to provide expert guidance to both existing and future clients.

Fabio Fagagnini, the CEO of Healthcare Holding Schweiz AG, expressed his views on the acquisition: "QUNIQUE represents a dynamic and fast-growing consultancy that perfectly complements our group's offerings as a medical technology distributor. With their experienced specialists now part of our extended family, our suppliers will benefit from enhanced support and comprehensive expertise in navigating industry regulations."

Angelina Hakim, the founder and CEO of QUNIQUE GmbH, who will join the leadership team of Healthcare Holding Schweiz, also expressed excitement about the merger. She emphasized, "This strategic alliance with Healthcare Holding Schweiz will unlock many opportunities for both parties. Together, we can more effectively support the entire value chain, from procurement to end-user, while continuing to provide our services independently. Our commitment to delivering comprehensive, customer-focused regulatory solutions across the MedTech industry remains unchanged."

About QUNIQUE GmbH

Headquartered in Wohlen, QUNIQUE GmbH specializes in creating customized strategies that help medical device and in-vitro diagnostics manufacturers maintain their regulatory compliance. The firm focuses on detailed analysis and practical implementations of regulatory requirements, including regulatory frameworks like IVDR (In Vitro Diagnostic Regulation) and MDR (Medical Device Regulation).

QUNIQUE also provides services as CH-REP and CH-Importer, facilitating international MedTech manufacturers' access to Swiss and EU markets. Their comprehensive offerings ensure that clients not only comply with current standards but are also prepared to adapt to future regulatory changes.

About Healthcare Holding Schweiz AG

Healthcare Holding Schweiz AG operates as a pivotal player in the Swiss medical technology market, utilizing a Buy, Build, and Technologize strategy for growth. Managed from Baar, the company is known for its ambitious expansion plan that includes making strategic acquisitions and partnerships, all while maintaining high standards for innovation and customer satisfaction.

Since 2023, the leadership of Fabio Fagagnini has been guiding the company's transition into new sectors, leveraging technology to optimize business processes and elevate service delivery. Healthcare Holding aims to remain at the forefront of the medical technology industry, setting benchmarks for excellence that not only enriches the company but also enhances the opportunities available to its employees.

Conclusion

The acquisition of QUNIQUE GmbH by Healthcare Holding Schweiz AG epitomizes a forward-thinking approach in the evolving landscape of medical technology. As these two entities join forces, the industry can anticipate a plethora of improvements in regulatory compliance and quality management, ultimately benefitting those reliant on strict adherence to these critical standards.